NextPlat Corp. (NASDAQ: NXPL, NXPLW) announced that its wholly owned pharmacy subsidiary, PharmcoRx, plans to introduce automated prescription dispensing kiosks from VendRx at select customer clinics and health care facilities. The kiosks will allow patients to obtain prescribed medications onsite following appointments and consultation with a PharmcoRx pharmacist, reducing the need for separate pharmacy visits.
Initial installations are planned for the fourth quarter of 2026, with broader deployment expected throughout 2027. The initiative is designed to improve medication access and adherence while expanding PharmcoRx's prescription services and relationships with health care providers. According to NextPlat, the kiosks could help address gaps in pharmacy access, particularly in underserved communities, while allowing clinics to offer prescription dispensing without additional staffing or onsite pharmacy construction. The company expects the program to create an additional prescription channel for PharmcoRx and support its expansion through independent clinics and health care providers.
VendRx reports approximately 80% formulary coverage per deployment and more than 90,000 successful prescription dispenses since inception, with no wrong-medication releases reported through Oct. 19, 2026, according to its internal records. That track record may be important for health care providers evaluating whether to adopt automated dispensing, as concerns about safety and reliability are central to any decision to hand off prescription fulfillment to a machine.
The move matters because medication nonadherence is a persistent and costly problem in U.S. health care, and reducing the friction of a separate pharmacy trip could help patients start and stay on prescribed therapies. For clinics, the kiosks offer a way to add dispensing without the expense of building an onsite pharmacy or hiring additional staff. For PharmcoRx, the program represents a new channel to capture prescription volume and deepen ties with independent clinics and health care providers.
NextPlat is a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the company seeks to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-Commerce presence and revenue. NextPlat currently operates an e-Commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care.
For investors, the announcement adds a tangible growth initiative to the company's pharmacy operations, though the financial impact will depend on how many kiosks are ultimately deployed and how quickly they gain traction with clinics. The latest news and updates relating to NXPL are available in the company's newsroom at https://ibn.fm/NXPL. To view the full press release, visit https://ibn.fm/dIWEa.
The announcement was distributed through BioMedWire, a specialized communications platform focused on the biotechnology, biomedical sciences, and life sciences sectors. BioMedWire is one of more than 75 brands within the Dynamic Brand Portfolio at IBN, which provides wire solutions through InvestorWire and offers editorial syndication to 5,000+ outlets.
